Z. Nitsan

发表

Repetitive Deep TMS for Parkinson Disease: A 3-Month Double-Blind, Randomized Sham-Controlled Study

A. Zangen, S. Hassin-Baer, G. Yahalom, 2018, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers

J. Aharon-Peretz, R. Gershoni-baruch, E. Dagan, 2012, Neurology.

Epidemiological and clinical characteristics of patients with late-onset Creutzfeldt-Jakob disease

J. Chapman, E. Kahana, S. Appel, 2022, Neurological Sciences.

Infective endocarditis mimicking parkinsonism and rapidly progressive dementia

A. Shenker, E. Kahana, A. Gelfand, 2016 .

Management of advanced Parkinson’s disease in Israel: Clinicians viewpoint and action items

D. Arkadir, R. Djaldetti, T. Gurevich, 2022, Frontiers in Aging Neuroscience.

Costeff syndrome: clinical features and natural history

D. Lev, A. Schweiger, B. Pode-Shakked, 2014, Journal of Neurology.

Progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukemia after immunosuppressive treatment

A. Gelfand, R. Milo, S. Appel, 2017 .

Genetic Creutzfeldt‐Jakob disease in Turkish Jews—demographic and clinical features

J. Chapman, E. Kahana, R. Milo, 2022, Acta neurologica Scandinavica.

Repetitive deep transcranial magnetic stimulation for motor symptoms in Parkinson's disease: A feasibility study

A. Zangen, R. Amiaz, S. Hassin-Baer, 2016, Clinical Neurology and Neurosurgery.

A case of tetanus infection following hand injury

D. Gefel, S. Maayan, R. Milo, 2018 .

Familial Creutzfeldt–Jakob disease with the E200K mutation: longitudinal neuroimaging from asymptomatic to symptomatic CJD

J. Chapman, A. Korczyn, Hedok Lee, 2015, Journal of Neurology.

CSF tau correlates with CJD disease severity and cognitive decline

J. Chapman, S. Appel, H. Rosenmann, 2016, Acta neurologica Scandinavica.

Unusual presentations in patients with E200K familial Creutzfeldt−Jakob disease

J. Chapman, C. Hoffmann, I. Kimiagar, 2016, European journal of neurology.

Characterization of sleep disorders in patients with E200K familial Creutzfeldt–Jakob disease

J. Chapman, A. Korczyn, E. Kahana, 2015, Journal of Neurology.

The Creutzfeldt–Jakob disease (CJD) neurological status scale: a new tool for evaluation of disease severity and progression

J. Chapman, I. Prohovnik, Sarit Appel, 2011, Acta neurologica Scandinavica.

CSF tau correlates with the degree of cortical involvement in E200K familial Creutzfeldt-Jakob disease

J. Chapman, A. Korczyn, E. Kahana, 2016, Neuroscience Letters.

Familial Creutzfeldt–Jakob disease homozygous to the E200K mutation: clinical characteristics and disease course

J. Chapman, A. Korczyn, E. Kahana, 2020, Journal of Neurology.

Disease duration in E200K familial Creutzfeldt–Jakob disease is correlated with clinical, radiological, and laboratory variables

J. Chapman, A. Korczyn, E. Kahana, 2018, Journal of Neural Transmission.

Pruritus in familial Creutzfeldt–Jakob disease: a common symptom associated with central nervous system pathology

Amos D. Korczyn, Joab Chapman, Chen Hoffman, 2010, Journal of Neurology.

Seizures in E200K familial and sporadic Creutzfeldt‐Jakob disease

J. Chapman, S. Appel, O. Cohen, 2015, Acta neurologica Scandinavica.

Clinical radiological correlation in E200K familial Creutzfeldt–Jakob disease

J. Chapman, A. Korczyn, E. Kahana, 2016, Journal of Neural Transmission.

The consequences of switching from Gilenya® to generics for fingolimod.

A. Gelfand, R. Milo, S. Appel, 2023, Multiple sclerosis and related disorders.

The Frontal Assessment Battery as a Tool for Evaluation of Frontal Lobe Dysfunction in Patients With Parkinson Disease

D. Tanné, E. Vakil, S. Hassin-Baer, 2012, Journal of geriatric psychiatry and neurology.

Educational Level as a Modulator of Cognitive Performance and Neuropsychyatric Features in Parkinson Disease

D. Tanné, E. Vakil, S. Hassin-Baer, 2007, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

Plasma Homocysteine Levels and Parkinson Disease: Disease Progression, Carotid Intima-media Thickness and Neuropsychiatric Complications

D. Tanné, J. Chapman, E. Vakil, 2006, Clinical neuropharmacology.

Mycosis fungoides – A cutaneous lymphoproliferative disorder in a patient treated with fingolimod for multiple sclerosis

R. Milo, S. Appel, Z. Nitsan, 2018, Journal of Clinical Neuroscience.

The epidemiological and clinical characteristics of patients with young-onset genetic Creutzfeldt-Jakob disease.

J. Chapman, S. Appel, O. Cohen, 2023, Neurological research.

Characterization of movement disorders in patients with familial Creutzfeldt-Jakob disease carrying the E200K mutation.

J. Chapman, A. Korczyn, R. Inzelberg, 2012, The Israel Medical Association journal : IMAJ.

Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson’s disease?

D. Tanné, J. Chapman, E. Vakil, 2011, Journal of Neural Transmission.

The association of quantitative EEG and MRI in Creutzfeldt‐Jakob Disease

J. Chapman, S. Gilat, S. Appel, 2019, Acta neurologica Scandinavica.